Ran Xu

1.7k total citations
52 papers, 1.3k citations indexed

About

Ran Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ran Xu has authored 52 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 19 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Ran Xu's work include Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (11 papers) and Circular RNAs in diseases (11 papers). Ran Xu is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (11 papers) and Circular RNAs in diseases (11 papers). Ran Xu collaborates with scholars based in China, Norway and Australia. Ran Xu's co-authors include Fushuang Zheng, Xuan Zhu, Anjing Chen, Kaiming Ren, Jungang Zhao, Jian Wang, Jingshan Huang, Haiqing He, Shuiqing Wu and Xiaokun Zhao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of The Electrochemical Society and Oncogene.

In The Last Decade

Ran Xu

51 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ran Xu China 22 879 583 167 146 81 52 1.3k
Xi Sun China 18 728 0.8× 263 0.5× 100 0.6× 179 1.2× 121 1.5× 36 1.2k
Xudong Guo China 20 1.0k 1.2× 556 1.0× 79 0.5× 107 0.7× 35 0.4× 57 1.3k
Ning Lü China 20 898 1.0× 409 0.7× 94 0.6× 235 1.6× 29 0.4× 48 1.3k
Lihua Li China 27 1.6k 1.8× 1.2k 2.1× 196 1.2× 208 1.4× 187 2.3× 105 2.2k
Zhi Nie China 13 1.7k 1.9× 764 1.3× 116 0.7× 253 1.7× 193 2.4× 49 2.1k
Ahmed I. Abulsoud Egypt 30 1.4k 1.6× 1.4k 2.4× 91 0.5× 237 1.6× 84 1.0× 94 2.0k
Xiangyu Wang China 16 640 0.7× 231 0.4× 72 0.4× 82 0.6× 43 0.5× 42 877
Meijun Du China 21 1.5k 1.7× 1.3k 2.2× 302 1.8× 168 1.2× 192 2.4× 54 2.2k
Yue Ming China 21 1.1k 1.2× 509 0.9× 134 0.8× 252 1.7× 33 0.4× 81 1.6k

Countries citing papers authored by Ran Xu

Since Specialization
Citations

This map shows the geographic impact of Ran Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Xu more than expected).

Fields of papers citing papers by Ran Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Xu. The network helps show where Ran Xu may publish in the future.

Co-authorship network of co-authors of Ran Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Xu. A scholar is included among the top collaborators of Ran Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Xu. Ran Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Zhanglong, Xiaoli Ma, Ran Xu, et al.. (2025). Quantitative deciphering of mechanical response mechanism in lithium-ion batteries via DIC-assisted indentation. Chemical Engineering Journal. 514. 163171–163171. 1 indexed citations
2.
He, Lina, Jie Lin, Hao Li, et al.. (2025). Long non-coding RNA NEAT1 promotes ovarian granulosa cell proliferation and cell cycle progression via the miR-29a-3p/IGF1 axis. Journal of Ovarian Research. 18(1). 6–6. 1 indexed citations
3.
Yan, Kun, Xueling Shen, Yi Cui, et al.. (2024). Clarifying the Impact of Electrode Material Heterogeneity on the Thermal Runaway Characteristics of Lithium‐Ion Batteries. SHILAP Revista de lepidopterología. 5(11). 3 indexed citations
4.
Yu, Zhanglong, Xueling Shen, Ran Xu, et al.. (2024). Understanding the combustion behavior of electric bicycle batteries and unveiling its relationship with fire extinguishing. Journal of Energy Chemistry. 91. 609–618. 7 indexed citations
5.
Xu, Ran, Ying Liu, Liang Ma, et al.. (2023). NQO1/CPT1A promotes the progression of pancreatic adenocarcinoma via fatty acid oxidation. Acta Biochimica et Biophysica Sinica. 55(5). 758–768. 1 indexed citations
6.
Zhu, Junchao, et al.. (2022). Comparison of Inflammatory Cytokine Levels between Single‐Port and Three‐Port Thoracoscopic Lobectomy in the Treatment of Non‐Small‐Cell Lung Cancer. BioMed Research International. 2022(1). 3240252–3240252. 2 indexed citations
7.
Chen, Jun, et al.. (2022). Recent Progress in Bio-Responsive Drug Delivery Systems for Tumor Therapy. Frontiers in Bioengineering and Biotechnology. 10. 916952–916952. 17 indexed citations
8.
Chen, Jun, et al.. (2021). Tumor-Acidity Responsive Polymeric Nanoparticles for Targeting Delivery of Angiogenesis Inhibitor for Enhanced Antitumor Efficacy With Decreased Toxicity. Frontiers in Bioengineering and Biotechnology. 9. 664051–664051. 3 indexed citations
9.
Zhang, Xin, Xuehai Wang, Ran Xu, et al.. (2021). Correction to: YM155 decreases radiation-induced invasion and reverses epithelial–mesenchymal transition by targeting STAT3 in glioblastoma. Journal of Translational Medicine. 19(1). 407–407. 2 indexed citations
11.
Xu, Ran, et al.. (2019). Circular RNA CDR1-AS contributes to pemetrexed and cisplatin chemoresistance through EGFR/PI3K signaling pathway in lung adenocarcinoma. Biomedicine & Pharmacotherapy. 123. 109771–109771. 51 indexed citations
12.
Ji, Jianxiong, Ran Xu, Kaikai Ding, et al.. (2019). Long Noncoding RNA SChLAP1 Forms a Growth-Promoting Complex with HNRNPL in Human Glioblastoma through Stabilization of ACTN4 and Activation of NF-κB Signaling. Clinical Cancer Research. 25(22). 6868–6881. 55 indexed citations
13.
14.
Wu, Shuiqing, Haiqing He, Ye Kang, et al.. (2019). MicroRNA-200c affects bladder cancer angiogenesis by regulating the Akt2/mTOR/HIF-1 axis. Translational Cancer Research. 8(8). 2713–2724. 14 indexed citations
15.
Zhu, Xiaolin, et al.. (2019). Analysis of ceRNA network identifies prognostic circRNA biomarkers in bladder cancer. Neoplasma. 66(5). 736–745. 18 indexed citations
16.
Han, Mingzhi, Ran Xu, Shuai Wang, et al.. (2018). Six-Transmembrane Epithelial Antigen of Prostate 3 Predicts Poor Prognosis and Promotes Glioblastoma Growth and Invasion. Neoplasia. 20(6). 543–554. 76 indexed citations
17.
Zhang, Xin, Qibing Huang, Xuehai Wang, et al.. (2017). Bufalin enhances radiosensitivity of glioblastoma by suppressing mitochondrial function and DNA damage repair. Biomedicine & Pharmacotherapy. 94. 627–635. 21 indexed citations
18.
Xu, Ran, Jianxiong Ji, Xin Zhang, et al.. (2017). PDGFA/PDGFRα-regulated GOLM1 promotes human glioma progression through activation of AKT. Journal of Experimental & Clinical Cancer Research. 36(1). 193–193. 38 indexed citations
19.
Ren, Kaiming, et al.. (2017). Knockdown of long non-coding RNA KCNQ1OT1 depressed chemoresistance to paclitaxel in lung adenocarcinoma. Cancer Chemotherapy and Pharmacology. 80(2). 243–250. 79 indexed citations
20.
Xu, Ran. (2010). Melting performance of CaO-SiO_2-Al_2O_3-MgO-TiO_2 slag system. Journal of University of Science and Technology Beijing. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026